These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20077568)

  • 1. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
    Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-targeted ubiquitin ligases in genome stability.
    Prudden J; Pebernard S; Raffa G; Slavin DA; Perry JJ; Tainer JA; McGowan CH; Boddy MN
    EMBO J; 2007 Sep; 26(18):4089-101. PubMed ID: 17762865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins with two SUMO-like domains in chromatin-associated complexes: the RENi (Rad60-Esc2-NIP45) family.
    Novatchkova M; Bachmair A; Eisenhaber B; Eisenhaber F
    BMC Bioinformatics; 2005 Feb; 6():22. PubMed ID: 15698469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of a SUMO isopeptidase to rDNA stabilizes silencing complexes by opposing SUMO targeted ubiquitin ligase activity.
    Liang J; Singh N; Carlson CR; Albuquerque CP; Corbett KD; Zhou H
    Genes Dev; 2017 Apr; 31(8):802-815. PubMed ID: 28487408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
    Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A SIM-ultaneous role for SUMO and ubiquitin.
    Perry JJ; Tainer JA; Boddy MN
    Trends Biochem Sci; 2008 May; 33(5):201-8. PubMed ID: 18403209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
    Prudden J; Perry JJ; Nie M; Vashisht AA; Arvai AS; Hitomi C; Guenther G; Wohlschlegel JA; Tainer JA; Boddy MN
    Mol Cell Biol; 2011 Jun; 31(11):2299-310. PubMed ID: 21444718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions.
    Santiago A; Godsey AC; Hossain J; Zhao LY; Liao D
    Cell Cycle; 2009 Jan; 8(1):76-87. PubMed ID: 19106612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry of SUMO promotes DNA repair.
    Prudden J; Perry JJ; Arvai AS; Tainer JA; Boddy MN
    Nat Struct Mol Biol; 2009 May; 16(5):509-16. PubMed ID: 19363481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of poly-SUMO chain recognition by the RNF4-SIMs domain.
    Kung CC; Naik MT; Wang SH; Shih HM; Chang CC; Lin LY; Chen CL; Ma C; Chang CF; Huang TH
    Biochem J; 2014 Aug; 462(1):53-65. PubMed ID: 24844634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
    Ding H; Yang Y; Zhang J; Wu J; Liu H; Shi Y
    Proteins; 2005 Dec; 61(4):1050-8. PubMed ID: 16224784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
    Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
    J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a human cell line stably overexpressing mouse Nip45 and characterization of Nip45 subcellular localization.
    Hashiguchi K; Ozaki M; Kuraoka I; Saitoh H
    Biochem Biophys Res Commun; 2013 Jan; 430(1):72-7. PubMed ID: 23159618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.